﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Tabriz University of Medical Sciences</PublisherName>
      <JournalTitle>Medical Journal of Tabriz University of Medical Sciences</JournalTitle>
      <Issn>2783-2031</Issn>
      <Volume>31</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2009</Year>
        <Month>06</Month>
        <DAY>22</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>The Ketogenic Diet for Refractory Childhood Epilepsy</ArticleTitle>
    <FirstPage>15</FirstPage>
    <LastPage>20</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Mohammad</FirstName>
        <LastName>Barzegar</LastName>
      </Author>
      <Author>
        <FirstName>Alireza</FirstName>
        <LastName>Ostad Rahimi</LastName>
      </Author>
      <Author>
        <FirstName>Skoofeh</FirstName>
        <LastName>Eslampour</LastName>
      </Author>
      <Author>
        <FirstName>Shahla</FirstName>
        <LastName>Shahbazi</LastName>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">
      </ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2009</Year>
        <Month>10</Month>
        <Day>31</Day>
      </PubDate>
    </History>
    <Abstract>Background and Objectives: The Ketogenic diet (KD) is a high fat, low protein and low carbohydrate, which controls refractory epilepsy. This prospective study sought to determine the ketogenic diet's effectiveness in children with refractory (to medication) epilepsy. Materials &amp; Methods: Forty three children, ages 2 to 14 years were treated with the classical KD from 2002 to 2006. Response to treatment (reduction of seizure frequency &gt; 50 %) tolerability and adverse events were analyzed. Results: Forty three children (mean age 5.8 years old), averaged 30 seizures per month before KD, despite on exposure to a mean 6.6 antiepileptic medications were treated with KD. At one month 93%, at 3 months 74%, at 6 months 51% and at 12 months 40% of patients remained on diet, 35% maintained the KD &gt;12 months. At one month 77%, at 3 months 65%, at 6 months 44% and at 12 months 35% of patients showed a reduction of seizure frequency of &gt;50%. Age, sex, seizure type and etiology did not predict response. Exposure more antiepileptic drugs before KD was with poor response at 12 months (P=0.007). High frequency of seizures before diet showed better response at 12 months (P=0.041). Most complications were mild and transient, but in 6 patients (14%) leads to discontinue the KD. Conclusion: The KD is an effective and safe treatment for children with refractory epilepsy.</Abstract>
  </Article>
</ArticleSet>